Compile Data Set for Download or QSAR
Report error Found 15 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase/endoribonuclease IRE2'
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human ERN2/IRE2 using myelin basic protein as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 17.4nMAssay Description:Inhibition of human ERN2 using MBP as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765075(US12391669, Compound 25)
Affinity DataIC50: 32nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 65.8nMAssay Description:Inhibition of human ERN2 using MBP as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765062(US12391669, Compound 96)
Affinity DataIC50: 120nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765063(US12391669, Compound 47)
Affinity DataIC50: 181nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  1.34E+3nMAssay Description:Binding affinity to human ERN2 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765076(US12391669, Compound 73)
Affinity DataIC50: 1.57E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765074(US12391669, Compound 84)
Affinity DataIC50: 1.98E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765064(US12391669, Compound 77)
Affinity DataIC50: 2.10E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  2.11E+3nMAssay Description:Binding affinity to human ERN2 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765071(US12391669, Compound 30)
Affinity DataIC50: 8.40E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765077(US12391669, Compound 16)
Affinity DataIC50: 1.00E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765078(US12391669, Compound 20)
Affinity DataIC50: 1.00E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase/endoribonuclease IRE2(Human)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM765067(US12391669, Compound 88)
Affinity DataIC50: 1.00E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent